Literature DB >> 22118169

Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting.

D B Banach1, T G Harris.   

Abstract

SETTING: Public chest clinics, New York City.
OBJECTIVE: To evaluate the association between patient characteristics and indeterminate QuantiFERON ® TB Gold (QFT-G) results and describe follow-up testing.
DESIGN: Retrospective cross-sectional multivariate logistic regression analyses of patients receiving QFT-G from October 2006 to June 2008. Analyses were performed separately depending on whether the indeterminate result was due to positive (low mitogen) or negative (high nil) control failure.
RESULTS: Of 28 864 individuals tested, 2058 (7%) tested positive, 26 284 (91%) negative, and 522 (2%) were indeterminate (low mitogen, n = 264; high nil, n = 258). Low mitogen results were more frequent among those aged < 10 years (OR(adj) 3.7, 95%CI 2.4-5.9), females (OR(adj) 1.4, 95%CI 1.1-1.8), Asians (OR(adj) 2.1, 95%CI 1.3-3.4) and the US-born (OR(adj) 1.9, 95%CI 1.4-2.6) and less frequent among Hispanics (OR(adj) 0.6, 95%CI 0.4-1.0). High nil results were more frequent among Hispanics (OR(adj) 1.7, 95%CI 1.0-2.8) and less frequent among the US-born (OR(adj) 0.6, 95%CI 0.5- 0.8). Among patients who received a repeat QFT-G (n = 137), 4% tested positive, 64% negative and 32% had a second indeterminate result, always of the same type.
CONCLUSION: Age, race/ethnicity and sex were associated with indeterminate QFT-G results. Most follow-up tests were negative, although a modest proportion were repeatedly indeterminate. Further studies evaluating the mechanisms of QFT-G indeterminate results are needed.

Entities:  

Mesh:

Year:  2011        PMID: 22118169     DOI: 10.5588/ijtld.11.0017

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON®-Gold Testing.

Authors:  Aldo Crossa; Jason Kessler; Tiffany G Harris
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

2.  High Proportion of Indeterminate QuantiFERON-TB Gold In-Tube Results in an Inpatient Population Is Related to Host Factors and Preanalytical Steps.

Authors:  Valeria Fabre; Shmuel Shoham; Kathleen R Page; Maunank Shah
Journal:  Open Forum Infect Dis       Date:  2014-09-19       Impact factor: 3.835

3.  Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population.

Authors:  Chin-Chung Shu; Chia-Lin Hsu; Chih-Yuan Lee; Vin-Cent Wu; Feng-Jung Yang; Jann-Yuan Wang; Chong-Jen Yu; Li-Na Lee
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

4.  Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection.

Authors:  Jody C Sharninghausen; Adrienne E Shapiro; David M Koelle; H Nina Kim
Journal:  Open Forum Infect Dis       Date:  2018-07-27       Impact factor: 3.835

5.  Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis.

Authors:  Noëmi R Meier; Thomas Volken; Marc Geiger; Ulrich Heininger; Marc Tebruegge; Nicole Ritz
Journal:  Front Pediatr       Date:  2019-05-29       Impact factor: 3.418

6.  Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control.

Authors:  Chin-Chung Shu; Meng-Kun Tsai; Shu-Wen Lin; Jann-Yuan Wang; Chong-Jen Yu; Chih-Yuan Lee
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

7.  CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis.

Authors:  Ping-Huai Wang; Shu-Yung Lin; Susan Shih-Jung Lee; Shu-Wen Lin; Chih-Yuan Lee; Yu-Feng Wei; Chin-Chung Shu; Jann-Yuan Wang; Chong-Jen Yu
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

8.  Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis.

Authors:  Chin-Chung Shu; Vin-Cent Wu; Feng-Jung Yang; Sung-Ching Pan; Tai-Shuan Lai; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

9.  Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.

Authors:  Chin-Chung Shu; Chia-Lin Hsu; Chih-Yuan Lee; Jann-Yuan Wang; Vin-Cent Wu; Feng-Jung Yang; Jann-Tay Wang; Chong-Jen Yu; Li-Na Lee
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

10.  Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay.

Authors:  Chin-Chung Shu; Chia-Lin Hsu; Yu-Feng Wei; Chih-Yuan Lee; Hung-Hsiang Liou; Vin-Cent Wu; Feng-Jung Yang; Hsien-Ho Lin; Jann-Yuan Wang; Jin-Shing Chen; Chong-Jen Yu; Li-Na Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.